Apple Adds Blood Oxygen to Watch: Will Wearables' Top Line Rise?

Apple AAPL added a redesigned Blood Oxygen feature to some Apple Watch Series 9, Series 10 and Apple Watch Ultra 2 users through an iPhone and Apple Watch software update. Once users with these models upgrade their paired iPhone to iOS 18.6.1 and Apple Watch to watchOS 11.6.1, they will have access to the redesigned Blood Oxygen feature.Apple Watch Series 9, Series 10 and Apple Watch Ultra 2 offer irregular rhythm notifications, the ECG app, Sleep Apnea Notifications, Fall Detection, sleep tracking, wrist temperature sensing, the Vitals app, the Noise app, the Medications app and the Mindfulness app. The addition of the Blood Oxygen feature, along with the upcoming watchOS 26, is expected to boost adoption, thereby driving Wearables, Home and Accessories sales.Wearables, Home and Accessories sales decreased 8.6% year over year to $7.4 billion and accounted for 7.9% of net sales in third-quarter fiscal 2025. The figure beat the consensus mark by 0.85%.The Zacks Consensus Estimate for Wearables, Home and Accessories sales is pegged at $8.32 billion, indicating an 8% decline from the figure reported in the year-ago quarter.Apple Faces Tough Competition in Wearables MarketAAPL is a major player in the wearables market but is facing stiff competition from the likes of Alphabet GOOGL and Garmin GRMN.Garmin’s expanding Venu and vivoactive smartwatch series, which boast new health and wellness features, including nap detection and enhanced sleep coaching, is a key catalyst. Garmin’s latest Venu 3 is gaining solid traction on the back of its rich wellness and fitness features. The company’s new music-enabled smartwatches integrated with Spotify and Deezer are gaining traction in the global wearables market. For 2025, Garmin expects fitness revenues to rise more than 25% year over year.Alphabet’s Gemini personal AI assistant is now available to Wear OS watches, including those from Google’s Pixel, Samsung, OPPO, OnePlus and Xiaomi. In February, Google received clearance from the U.S. Food and Drug Administration (FDA) for the Loss of Pulse Detection feature starting with the Pixel Watch 3. The device offers safety and health features like Car Crash Detection, Fall Detection, Irregular Heart Rhythm Notifications, and the ECG app and Safety Check.AAPL’s Share Price Performance, Valuation & EstimatesApple shares have dropped 7.8% year to date, underperforming the broader Zacks Computer and Technology sector’s return of 13.9%.Apple Stock’s Performance Image Source: Zacks Investment Research The APPL stock is trading at a premium, with a forward 12-month Price/Earnings of 29.75X compared with the broader sector’s 28.19X. AAPL has a Value Score of F.AAPL Valuation Image Source: Zacks Investment Research The Zacks Consensus Estimate for fiscal 2025 earnings is pegged at $7.33 per share, up 3.2% over the past 30 days, suggesting 8.6% year-over-year growth.Apple Inc. Price and Consensus  Apple Inc. price-consensus-chart | Apple Inc. QuoteApple currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.See our %%CTA_TEXT%% report – free today!7 Best Stocks for the Next 30 DaysWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Apple Inc. (AAPL): Free Stock Analysis Report Garmin Ltd. (GRMN): Free Stock Analysis Report Alphabet Inc. (GOOGL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks